← Eichor
Condition: Alzheimer Disease With Delusions Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Alzheimer Disease With Delusions

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
Phase 2 · 3 location(s) · MapLight Therapeutics · NCT07459660Tau Networks in Psychotic Alzheimer's Disease
Phase N/A · 1 location(s) · Northwell Health · NCT05847192A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Phase 2 · 40 location(s) · MapLight Therapeutics · NCT06887192ACP-204 in Adults With Alzheimer's Disease Psychosis
Phase 2/Phase 3 · 148 location(s) · ACADIA Pharmaceuticals Inc. · NCT06159673
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.